Search

Yossi Rosman,1,2 Linoy Gabay,3 Tami Landau,3 Ronit Confino-Cohen1,2 1Allergy and Clinical Immunology Unit, Meir Medical Center, Kfar Saba, Israel; 2Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; 3Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, IsraelCorrespondence: Yossi RosmanAllergy and Clinical Immunology Unit, Meir Medical Center, Tshernichovsky Street 59, Kfar Saba, 4428164, IsraelTel/Fax +1 972 37372717Email rosmanyossi@gmail.comBackground: Childhood asthma is the most common chronic disease throughout the western world. Improving asthma control is a leading health management goal.Purpose: To evaluate the effect of an intervention by a visit to an asthma specialist on asthma control in children.Materials and Methods: This retrospective study was conducted using the electronic database of Maccabi Health Services. All members ages 5– 16 with an asthma diagnosis during 2000– 2016, and at least one visit to a specialist were included. Asthma outcomes during the 2 years before and after the visit to the asthma specialist were compared.Results: A total of 37,066 children were diagnosed with asthma. Among them, 13,533 (36.5%) had at least one visit to an asthma specialist and were included. Children with asthma visited their primary care physician more often in the period before the specialist visit (4.4± 4.4 vs 3.16± 3.9 visits, respectively; p< 0.01). After visiting a specialist, average number of visits to emergency departments (0.52± 1.3 vs 0.45± 1), all cause hospitalizations (0.13± 0.45 vs 0.08± 0.4) and hospitalizations due to asthma exacerbations (0.08± 0.345 vs 0.05± 0.3) decreased (p< 0.01 for all comparisons). Prescription of short-acting beta agonists decreased (2.85± 3.6 vs 2.2 ± 3.7, p< 0.01) and inhaled steroid prescriptions increased (1.9± 2.9 vs 2.7± 3.7, p< 0.01), respectively, after the intervention. A substantial reduction in the prescription of corticostero

Yossi Rosman,1,2 Linoy Gabay,3 Tami Landau,3 Ronit Confino-Cohen1,2 1Allergy and Clinical Immunology Unit, Meir Medical Center, Kfar Saba, Israel; 2Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; 3Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, IsraelCorrespondence: Yossi RosmanAllergy and Clinical Immunology Unit, Meir Medical Center, Tshernichovsky Street 59, Kfar Saba, 4428164, IsraelTel/Fax +1 972 37372717Email rosmanyossi@gmail.comBackground: Childhood asthma is the most common chronic disease throughout the western world. Improving asthma control is a leading health management goal.Purpose: To evaluate the effect of an intervention by a visit to an asthma specialist on asthma control in children.Materials and Methods: This retrospective study was conducted using the electronic database of Maccabi Health Services. All members ages 5– 16 with an asthma diagnosis during 2000– 2016, and at least one visit to a specialist were included. Asthma outcomes during the 2 years before and after the visit to the asthma specialist were compared.Results: A total of 37,066 children were diagnosed with asthma. Among them, 13,533 (36.5%) had at least one visit to an asthma specialist and were included. Children with asthma visited their primary care physician more often in the period before the specialist visit (4.4± 4.4 vs 3.16± 3.9 visits, respectively; p< 0.01). After visiting a specialist, average number of visits to emergency departments (0.52± 1.3 vs 0.45± 1), all cause hospitalizations (0.13± 0.45 vs 0.08± 0.4) and hospitalizations due to asthma exacerbations (0.08± 0.345 vs 0.05± 0.3) decreased (p< 0.01 for all comparisons). Prescription of short-acting beta agonists decreased (2.85± 3.6 vs 2.2 ± 3.7, p< 0.01) and inhaled steroid prescriptions increased (1.9± 2.9 vs 2.7± 3.7, p< 0.01), respectively, after the intervention. A substantial reduction in the prescription of corticostero